Published in Hepatitis Weekly, March 4th, 1996
The report was one of several evaluating procollagen III peptide (PIIIP) levels in interferon-treated hepatitis patients presented at the VII International Symposium on Viral Hepatitis, held January 25-27, 1996 in Madrid, Spain.
Researcher A.M.G. Farci and colleagues evaluated whether the fibrogenesis marker PIIIP could be a useful predictive parameter of response to interferon-alpha by studying 28 patients (21 men, seven women) who had histologically documented chronic active...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.